Crossmark

Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials

Crossref DOI link: https://doi.org/10.1186/s12929-016-0289-5

Published Online: 2016-11-04

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Li-Tzu

Ting, Chiao-Hsuan

Yen, Men-Luh

Liu, Ko-Jiunn

Sytwu, Huey-Kang

Wu, Kenneth K.

Yen, B. Linju
Funding

Funding for this research was provided by:

Ministry of Science and Technology, Taiwan (MOST-104-2321-B-400-021, MOST-104-2314-B-400-002)

National Health Research Institutes (CS-105-PP-06)